Alpha Cognition (ACOG) Change in Accured Expenses (2023 - 2025)
Alpha Cognition (ACOG) posted quarterly Change in Accured Expenses of $2.4 million for Q4 2025, up 249.46% year-over-year from $695693.0 in Q4 2024, and down 34.67% quarter-over-quarter from $3.7 million in Q3 2025.
Alpha Cognition (ACOG) Change in Accured Expenses (2023 - 2025) Analysis & Trends
Alpha Cognition's Change in Accured Expenses history runs 3 years deep, the most recent figure standing at $2.4 million for Q4 2025.
- In Q4 2025, Change in Accured Expenses rose 249.46% year-over-year to $2.4 million; the TTM figure through Dec 2025 stood at $6.5 million (up 523.9% YoY), while the FY2025 annual figure was $6.5 million, up 523.9% from the prior year.
- Change in Accured Expenses for Q4 2025 stood at $2.4 million, down from $3.7 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $3.7 million in Q3 2025, with the low at -$503743.0 in Q1 2024.
- The 3-year median for Change in Accured Expenses is $426611.0 (2024), against an average of $794729.5.
- Peak annual rise in Change in Accured Expenses reached 642.22% in 2025, while the deepest fall reached 31.8% in 2025.
- Alpha Cognition's Change in Accured Expenses stood at -$138535.0 in 2023, then jumped by 602.18% to $695693.0 in 2024, then soared by 249.46% to $2.4 million in 2025.
- Business Quant data shows ACOG's Change in Accured Expenses at $2.4 million in Q4 2025, $3.7 million in Q3 2025, and $239961.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 212.44 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 61.62 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 68.82 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Alpha Cognition | 219.48 Mn | 178.04 Mn | 5.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.43 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Sep 30, 2025 | 3.72 Mn |
| Jun 30, 2025 | 239,961.00 |
| Jun 30, 2025 | 239,961.00 |
| Mar 31, 2025 | 128,572.00 |
| Mar 31, 2025 | 128,572.00 |
| Dec 31, 2024 | 695,693.00 |
| Dec 31, 2024 | 695,693.00 |
| Sep 30, 2024 | 501,359.00 |
| Sep 30, 2024 | 501,359.00 |
| Jun 30, 2024 | 351,863.00 |
| Jun 30, 2024 | 351,863.00 |
| Mar 31, 2024 | -503,743.00 |
| Mar 31, 2024 | -503,743.00 |
| Dec 31, 2023 | -138,535.00 |
| Dec 31, 2023 | -138,535.00 |
| Sep 30, 2023 | 519,803.00 |
| Sep 30, 2023 | 519,803.00 |